AS
BIO icon

Altshuler Shaham’s Bio-Rad Laboratories Class A BIO Stock Holding History

Altshuler Shaham’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-61
Closed -$46K – 540
2021
Q3 		$46K Buy
+61
New +$45.7K ﹤0.01% 429
2021
Q1 		– Sell
-13
Closed -$8K – 461
2020
Q4 		$8K Sell
13
-55
-81% -$31.3K ﹤0.01% 361
2020
Q3 		$35K Buy
68
+12
+21% +$6.08K ﹤0.01% 267
2020
Q2 		$25K Buy
+56
New +$24.7K ﹤0.01% 243
2019
Q4 		– Sell
-28
Closed -$9K – 507
2019
Q3 		$9K Sell
28
-7
-20% -$2.28K ﹤0.01% 290
2019
Q2 		$11K Buy
+35
New +$10.5K ﹤0.01% 271

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Altshuler Shaham's BIO Position: Q4 2021 in Review

Altshuler Shaham sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2021, closing a stake of 61 shares — an estimated $46K sold.

Altshuler Shaham first reported a position in BIO in Q2 2019 and held it in 6 quarters. The position peaked at $46K in Q3 2021. 533 funds tracked by Wall St. Rank hold BIO as of Q4 2021.

  • Altshuler Shaham reported no remaining Bio-Rad Laboratories Class A position as of Q4 2021 after selling out during the quarter.
  • Altshuler Shaham sold 61 Bio-Rad Laboratories Class A shares in Q4 2021, an estimated $46K.
  • Altshuler Shaham first reported a position in Bio-Rad Laboratories Class A in Q2 2019 and held it in 6 quarters.
  • Altshuler Shaham's Bio-Rad Laboratories Class A position peaked at $46K in Q3 2021.
  • 533 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2021.

Based on Altshuler Shaham's 13F filing for Q4 2021, filed 15 Feb 2022.